S-5287-119
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsored by Jon Ossoff (D-GA)
What it does
This bill would authorize the CDC to award competitive grants to states, territories, and the District of Columbia to fund outreach, education, and early detection efforts for colorectal cancer in people under 45. Grant funds could be used for public awareness campaigns, provider training, patient navigation, risk assessment tools, and monitoring screening quality, with grants lasting five years and renewable at HHS's discretion. The bill authorizes "such sums as may be necessary" without specifying a dollar amount.
Who benefits
Younger adults (under 45) at elevated risk of colorectal cancer due to family history, inflammatory bowel disease, or inherited syndromes; underserved and rural populations; American Indian, Alaska Native, and African American communities; individuals with type 2 diabetes; state health departments and CDC-funded programs; hospitals, clinics, Tribal organizations, nonprofits, and universities that partner on grant-funded activities; and healthcare providers who receive training on early detection.
Who is hurt
Federal taxpayers who would fund the unspecified appropriations; states that do not win competitive grants may see continued funding disparities; states with limited grant-writing capacity may be less able to compete for funds; and health systems in non-recipient states would not see the same infusion of resources for outreach and screening infrastructure.
Supporters argue
Supporters argue that colorectal cancer diagnoses among people under 50 are rising sharply and are projected to become the leading cause of cancer deaths in that age group by 2030, making targeted early detection funding urgent. They contend that giving states flexible, competitive grants allows them to tailor outreach to high-risk groups—including those with family history, IBD, or inherited syndromes—and underserved populations, potentially catching cancers earlier when treatment is more effective and less costly.
Opponents argue
Opponents argue that the bill authorizes open-ended spending without specifying a funding ceiling, making it difficult to assess the true fiscal cost or ensure accountability. They contend that a competitive grant structure may favor states with more sophisticated grant-writing resources, potentially leaving rural or under-resourced states with the greatest need less able to secure funding, and that a five-year reporting cycle limits ongoing oversight of how funds are used.
Constitutional context
Congress's authority to fund this grant program derives from the Spending Clause (Article I, Section 8, Clause 1), which permits Congress to appropriate funds for the general welfare, including public health initiatives administered through voluntary state grants. Because state participation is voluntary and grants are competitive rather than conditioned on broader policy compliance, this does not raise the coercion concerns identified in NFIB v. Sebelius regarding conditional federal funding.
Checks and balances
Congress authorizes the grant program and appropriates funds, while the Secretary of Health and Human Services and the CDC Director hold discretion over grant criteria, awards, and renewals, with reporting requirements providing limited congressional oversight.
Historical precedent
Congress has previously funded CDC cancer screening programs, such as the National Breast and Cervical Cancer Early Detection Program, using similar state grant structures.